Histogen Inc. (HSTO) Financials

HSTO Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 5.8 million 1.4 million
2023-06-30 13.5 million 5.3 million
2023-03-31 16.1 million 5.7 million
2022-12-31 19.1 million 5.7 million

HSTO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -2.7 million -7000
2023-06-30 -2.4 million 32000
2023-03-31 -2.6 million 419000
2022-12-31 -2.4 million 89000

HSTO Net Income

No data available :(

HSTO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 4.6 million - -
2023-06-30 7.3 million - 4.5 million
2023-03-31 9.7 million - 4.6 million
2022-12-31 12.1 million - 4.6 million

HSTO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 4.3 million
2023-06-30 4.3 million
2023-03-31 4.3 million
2022-12-31 3.2 million

HSTO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 660000 2.9 million -
2023-06-30 - 536000 1.6 million -
2023-03-31 - 993000 2.5 million -
2022-12-31 1000 1.1 million 1.9 million -

HSTO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 5000 -
2023-06-30 5000 -
2023-03-31 5000 -
2022-12-31 4000 -

HSTO

Price: $0.15

52 week price:
0.10
1.22

Earnings Per Share: -2.81 USD

P/E Ratio: -0.12

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Volume: 31330

Market Capitalization: 1.5 million

Links: